Form 4: Guardant Health Director Krognes Exercises RSUs

Guardant Health Director Steve Krognes acquired 154 shares of common stock via restricted stock unit vesting.

Summary

• Steve E. Krognes, a Director of Guardant Health, Inc. (GH), acquired 154 shares of common stock on July 31, 2025.
• This acquisition resulted from the vesting of restricted stock units (RSUs) at a price of $0 per share.
• Following this transaction, Krognes beneficially owns 17,973 shares of common stock.
• He also holds 1,698 unvested restricted stock units.
• The RSUs were granted on August 9, 2022, with 25% vesting on June 30, 2023, and the remaining 75% vesting monthly over three years from that date.

Sentiment

Score: 7

Explanation: The filing reports a routine vesting of restricted stock units for a director, which is an expected compensation event. While it increases insider ownership, it does not indicate new strategic moves or significant financial performance changes.

Positives

• Director Steve Krognes increased his direct beneficial ownership of Guardant Health common stock by 154 shares.
• The transaction reflects the ongoing vesting of previously granted restricted stock units, aligning director interests with shareholder value.

Negatives

• No negative aspects are indicated in this routine insider transaction filing.

Risks

• No specific risks are disclosed in this Form 4 filing, which primarily reports an insider transaction.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Management Comments

• No direct management comments or quotes are included in this Form 4 filing.

Industry Context

This Form 4 filing is a routine insider transaction report and does not provide information related to broader industry trends or competitors.

Comparison to Industry Standards

• This Form 4 filing does not contain information that allows for a comparison of company results against global benchmarks or specific comparable companies.

Stakeholder Impact

• Shareholders: The increase in director ownership through RSU vesting aligns the director's financial interests more closely with those of the shareholders.

Next Steps

• The remaining 1,698 restricted stock units held by Steve Krognes are expected to continue vesting in substantially equal monthly installments until June 30, 2026.

Key Dates

Keywords

Guardant Health, GH, Steve Krognes, Director, Form 4, SEC filing, insider transaction, stock acquisition, RSU vesting, common stock, beneficial ownership